ID Biomedical
This article was originally published in The Gray Sheet
Executive Summary
Shipments of the Velogene rapid assay used in identification of methicillin resistant Staphylococcus aureus (MRSA) will commence by the end of the third quarter following 510(k) clearance, announced July 14. Sybron International subsidiary Alexon-Trend will be the firm's international marketing and distribution partner for the test, which is intended for use in hospital laboratories